Clinic
Memorial Community Hospital Corporation
Memorial Community Hospital Corporation was paid $1.27M by Medicaid between Jan 2018 and Aug 2024, across 59 billing codes. Its largest line is 99282, Emergency department visit for the evaluation and management, low to moderate severity — 15% of everything it billed.
33Billing provider infoMEMORIAL COMMUNITY HOSPITAL CORPORATION
BLAIR, NE 68008
BLAIR, NE 68008
33aNPI1265408819assigned 02/24/2006
33bProvider typeCritical Access Hospital Clinic/Center
28Total paid$1.27M
24GClaims30,098
24DCodes billed59
24AFirst – last monthJan 2018 – Aug 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,378 | $139K | |
| 2019 | 3,188 | $124K | |
| 2020 | 3,842 | $158K | |
| 2021 | 8,057 | $358K | |
| 2022 | 9,534 | $416K | |
| 2023 | 1,355 | $54K | |
| 2024incomplete | 744 | $25K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 15% | 1,627 | 1,357 | $195K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 1,429 | 1,023 | $172K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 1,377 | 785 | $155K |
| 80053 | Comprehensive metabolic panel | 9.2% | 3,391 | 2,676 | $117K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.2% | 3,801 | 2,843 | $79K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 4.9% | 731 | 695 | $62K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.9% | 977 | 727 | $50K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.8% | 555 | 505 | $36K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.2% | 567 | 132 | $28K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.0% | 75 | 58 | $26K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.9% | 182 | 105 | $24K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.8% | 616 | 589 | $23K |
47 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 375 | $20K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 402 | $19K |
| 80061 | Lipid panel | 1.4% | 675 | $18K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.4% | 303 | $17K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.2% | 617 | $16K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.2% | 940 | $15K |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 2,569 | $15K |
| 84484 | 1.2% | 493 | $15K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 353 | $15K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.1% | 617 | $14K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 321 | $12K |
| J3490 | Unclassified drugs | <1% | 900 | $11K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 553 | $11K |
| 83605 | <1% | 470 | $10K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 140 | $9K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 448 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 224 | $9K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 474 | $8K |
| 81001 | <1% | 645 | $8K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 525 | $7K |
| 80050 | General health panel | <1% | 39 | $6K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 120 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 94 | $5K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 72 | $4K |
| 81003 | <1% | 910 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 171 | $3K |
| 87040 | <1% | 82 | $2K | |
| 87634 | <1% | 82 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 88 | $2K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 12 | $2K |
| 85027 | <1% | 91 | $2K | |
| 83655 | <1% | 41 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 61 | $1K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 362 | $1K |
| 87077 | <1% | 77 | $1K | |
| 87081 | <1% | 40 | $1K | |
| 84145 | <1% | 33 | $1K | |
| 86140 | <1% | 36 | $1K | |
| 81025 | <1% | 59 | $1K | |
| 86803 | <1% | 15 | $597.28 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 13 | $586.69 |
| 87186 | <1% | 26 | $552.63 | |
| 82962 | <1% | 41 | $466.09 | |
| 85018 | <1% | 79 | $372.47 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 22 | $274.62 |
| J2704 | Injection, propofol, 10 mg | <1% | 22 | $241.52 |
| 85610 | <1% | 38 | $62.53 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialZIMMER, AMY (CNE/VP PATIENT CARE SERVICES)
Parent organizationMEMORIAL COMMUNITY HOSPITAL CORPORATION
| Provider | Location | Paid |
|---|---|---|
| Memorial Community Hospital Corporation | Blair, NE | $1.84M |
| Memorial Community Hospital Corporation | Tekamah, NE | $271K |
| Memorial Community Hospital Corporation | Blair, NE | $78K |
| Memorial Community Hospital Corporation | Fort Calhoun, NE | $37K |
| Memorial Community Hospital Corporation | Tekamah, NE | $1K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.